| Literature DB >> 25424415 |
Wesley N Sivak1, James D White2, Jacqueline M Bliley1, Lee W Tien2, Han Tsung Liao1,3, David L Kaplan2, Kacey G Marra1,4,5.
Abstract
Nerve conduits are a proven strategy for guiding axon regrowth following injury. This study compares degradable silk-trehalose films containing chondroitinase ABC (ChABC) and/or glial cell line-derived neurotrophic factor (GDNF) loaded within a silk fibroin-based nerve conduit in a rat sciatic nerve defect model. Four groups of silk conduits were prepared, with the following silk-trehalose films inserted into the conduit: (a) empty; (b) 1 µg GDNF; (3) 2 U ChABC; and (4) 1 µg GDNF/2 U ChABC. Drug release studies demonstrated 20% recovery of GDNF and ChABC at 6 weeks and 24 h, respectively. Six conduits of each type were implanted into 15 mm sciatic nerve defects in Lewis rats; conduits were explanted for histological analysis at 6 weeks. Tissues stained with Schwann cell S-100 antibody demonstrated an increased density of cells in both GDNF- and ChABC-treated groups compared to empty control conduits (p < 0.05). Conduits loaded with GDNF and ChABC also demonstrated higher levels of neuron-specific PGP 9.5 protein when compared to controls (p < 0.05). In this study we demonstrated a method to enhance Schwann cell migration and proliferation and also foster axonal regeneration when repairing peripheral nerve gap defects. Silk fibroin-based nerve conduits possess favourable mechanical and degradative properties and are further enhanced when loaded with ChABC and GDNF.Entities:
Keywords: GDNF; chondroitinase ABC; drug delivery; nerve conduit; peripheral nerve; silk fibroin
Mesh:
Substances:
Year: 2014 PMID: 25424415 DOI: 10.1002/term.1970
Source DB: PubMed Journal: J Tissue Eng Regen Med ISSN: 1932-6254 Impact factor: 3.963